Showing 1,221 - 1,240 results of 1,518 for search '"kidney failure"', query time: 0.13s Refine Results
  1. 1221

    Atopy as an independent predictor for long-term patient and graft survival after kidney transplantation by Raphaël Porret, Raphaël P. H. Meier, Josip Mikulic, Manuel Pascual, Vincent Aubert, Thomas Harr, Déla Golshayan, Yannick D. Muller

    Published 2022-10-01
    “…No significant difference was found for gender, cold/warm ischemia time, preformed donor-specific antibodies (DSA), HLA mismatches, induction and maintenance immunosuppressive therapy, CMV serostatus, or cause of kidney failure. Patient and graft survival at ten years of follow-up were significantly better in the atopic group, 95.2% versus 69.2% patient survival (P < 0.001), and 87.9% versus 60.8% graft survival (P < 0.001), respectively. …”
    Get full text
    Article
  2. 1222

    The dire need for improved management of chronic kidney disease – associated hypertension in Pakistan by Hussain Mansoor, Marium Kauser Siddiqui, Imaduddin Sawal

    Published 2022-03-01
    “… Chronic Kidney Disease (CKD) refers to various kidney disorders ranging from mild to severe chronic kidney failure. Because of its escalating incidence and mortality rates, CKD is a serious public health concern in Pakistan. …”
    Get full text
    Article
  3. 1223

    What are the observed procedural costs of vascular access surgery? Protocol for a systematic review by Karen Stevenson, Andrew Jackson, Catrin Jones, Peter Thomson, Ram Kasthuri, David Kingsmore, Lucian Gaianu, Emma Aitken, Ben Edgar, Callum Stove

    Published 2024-01-01
    “…The treatment of kidney failure requires a significant volume of resources, and vascular access provision is the main modifiable cost. …”
    Get full text
    Article
  4. 1224

    Conventional Biological versus Sutureless Aortic Valve Prostheses in Combined Aortic and Mitral Valve Replacement by Alina Zubarevich, Marcin Szczechowicz, Arian Arjomandi Rad, Lukman Amanov, Arjang Ruhparwar, Alexander Weymann

    Published 2023-03-01
    “…There was no significant difference in the occurrence of postoperative major adverse events such as death, stroke, myocardial infarction and kidney failure between the groups. There was also no significant difference in the permanent pacemaker implantation rate, paravalvular leakage or valve dislocation. …”
    Get full text
    Article
  5. 1225

    Evaluation of Vancomycin Resistant Enterecoccal Infections by Fatma Kacar, Esma Eroğlu, Arzu Tarakçı, Fatma Derin Çölkesen, Şule Özdemir Armağan, Selver Can

    Published 2022-03-01
    “…The most common risk factors in patients were advanced age, urinary and central venous catheters, acute kidney injury or chronic kidney failure. The use of glycopeptides before VRE infection was 42.85%, and 100% of patients had previously used 3rd generation cephalosporins.Conclusion:The more important the isolation, correct identification and determination of antibiotic susceptibility in the infections caused by enterococci, the more vital it is to monitor the antibiotic susceptibility profiles for these bacteria.…”
    Get full text
    Article
  6. 1226

    Cerebellar infarction risk in a mild COVID-19 case by Antigona Kabashi, MD, PhD, Henri Fero, MD, Artiona Gjini, MD, Diana Dhimitri, MD, Mimoza Spahiu, MD, Fjolla Hyseni, MD, PhD, Edlira Harizi, MD, Kledisa Shemsi, MD, Valon Vokshi, MD, Arlind Decka, MD, Asm al Amin, MD, Ahm Ataullah, MD, Livia Capi, MD, Sepideh Jahanian, MD, Fareeha Nasir, MD, Ivan N. Ayala, MD, Juna Musa, MD, MS, Jeton Shatri, MD, PhD, Kreshnike Dedushi, MD, PhD, Florim Leniqi, MD, Guri Hyseni, MD

    Published 2023-02-01
    “…Thrombotic events in SARS-COV-2 disease patients are frequent, especially in patients with comorbidities such as heart failure, hypertension, cancer, diabetes mellitus, kidney failure, vascular disease, and other pulmonary illnesses. …”
    Get full text
    Article
  7. 1227

    Alternatively Spliced Landscape of PPARγ mRNA in Podocytes Is Distinct from Adipose Tissue by Claire Bryant, Amy Webb, Alexander S. Banks, Dawn Chandler, Rajgopal Govindarajan, Shipra Agrawal

    Published 2022-11-01
    “…Podocytes are highly differentiated epithelial cells, and their structural and functional integrity is compromised in a majority of glomerular and renal diseases, leading to proteinuria, chronic kidney disease, and kidney failure. Traditional agonists (e.g., pioglitazone) and selective modulators (e.g., GQ-16) of peroxisome-proliferator-activated-receptor-γ (PPARγ) reduce proteinuria in animal models of glomerular disease and protect podocytes from injury via PPARγ activation. …”
    Get full text
    Article
  8. 1228

    Potential Effects of Sweet Potato (<i>Ipomoea batatas</i>) in Hyperglycemia and Dyslipidemia—A Systematic Review in Diabetic Retinopathy Context by Ruth Naomi, Hasnah Bahari, Muhammad Dain Yazid, Fezah Othman, Zainul Amiruddin Zakaria, Mohd Khairi Hussain

    Published 2021-10-01
    “…Numerous drugs have been approved by officials to treat these conditions, but usage of any synthetic drugs in the long term will result in unavoidable side effects such as kidney failure. Therefore, more emphasis is being placed on natural ingredients due to their bioavailability and absence of side effects. …”
    Get full text
    Article
  9. 1229

    The Impact of Nutritional Status on Sexual Function in Male Kidney Transplant Recipients by Diana Sukackiene, Robertas Adomaitis, Marius Miglinas

    Published 2023-02-01
    “…<i>Materials and Methods</i><span style="font-variant: small-caps;">:</span> Fifty-four men with kidney failure who had undergone replacement therapy entered the study. …”
    Get full text
    Article
  10. 1230

    Cell surface GRP78 regulates TGFβ1-mediated profibrotic responses via TSP1 in diabetic kidney disease by Jackie Trink, Usman Ahmed, Kian O’Neil, Renzhong Li, Bo Gao, Joan C. Krepinsky

    Published 2023-02-01
    “…Introduction: Diabetic kidney disease (DKD) is the leading cause of kidney failure in North America, characterized by glomerular accumulation of extracellular matrix (ECM) proteins. …”
    Get full text
    Article
  11. 1231

    eGFRcystatinC/eGFRcreatinine ratio < 0.6 in patients with SARS-CoV-2 pneumonia: a prospective cohort study by Lauris Avotins, Juta Kroica, Aivars Petersons, Dace Zentina, Zaiga Kravale, Anna Saulite, Karlis Racenis

    Published 2023-09-01
    “…Factors that influence this ratio are complex and, in addition to the possible shrinkage of pores, other conditions such as thickening of glomerular basal membrane, comorbidities, prerenal kidney failure and others may play an important role and should be addressed when diagnosing SPS. …”
    Get full text
    Article
  12. 1232

    Advances in Membranous Nephropathy by Pierre Ronco, Emmanuelle Plaisier, Hanna Debiec

    Published 2021-02-01
    “…MN is the most common cause of nephrotic syndrome in adults leading to severe thrombotic complications and kidney failure. This review is focused on the recent therapeutic and pathophysiological advances that occurred in the last two years. …”
    Get full text
    Article
  13. 1233

    WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? by S. N. Tereshchenko, I. V. Zhirov

    Published 2016-01-01
    “…The highest refractoriness to CHF therapy was in patients with chronic kidney failure, atrial fibrillation and anemia (odds efficiency was 2.2, 2.9 and 3.1%, respectively). …”
    Get full text
    Article
  14. 1234

    Death and Dialysis Following Discharge From Chronic Kidney Disease Clinic: A Retrospective Cohort Study by Michael Che, Eduard Iliescu, Susan Thanabalasingam, Andrew G Day, Christine A White

    Published 2022-08-01
    “…In Ontario, Canada, the eligibility criteria for multidisciplinary CKD care funding were revised between 2016 and 2018 to a 2 year risk of kidney replacement therapy (KRT) greater than 10% calculated by the 4-variable Kidney Failure Risk Equation (KFRE). Implementation of the risk-based approach has led to the discharge of prevalent CKD patients. …”
    Get full text
    Article
  15. 1235

    Urinary Prostaglandin E2 Excretion and the Risk of Cardiovascular and Kidney Disease by Frank Geurts, Layal Chaker, Anna C. van der Burgh, Deirdre Cronin‐Fenton, Robert A. Fenton, Ewout J. Hoorn

    Published 2024-02-01
    “…Longitudinal associations with cardiovascular mortality and kidney outcomes (eGFR <60 or <45 mL/min per 1.73 m2 and the composite outcome 40% eGFR loss or kidney failure) were assessed with Cox regression. Urinary PGE2 and PGEM excretions were higher with increasing age, lower eGFR, smoking, diabetes, and albuminuria. …”
    Get full text
    Article
  16. 1236

    Big data analytics for MerTK genomics reveals its double-edged sword functions in human diseases by Shijie Liu, Jinzi Wu, Daixuan Yang, Jianliang Xu, Hang Shi, Bingzhong Xue, Zufeng Ding

    Published 2024-04-01
    “…Finally, based on our proteomics from primary human aortic ECs, we validated the functions of MerTK in several human diseases, such as cancer, aging, kidney failure and heart failure. Conclusions: Our big data analytics suggest that MerTK may be a promising therapeutic target, but how it should be modulated depends on the disease types and sex differences. …”
    Get full text
    Article
  17. 1237

    Lysozyme promotes renal fibrosis through the JAK/STAT3 signal pathway in diabetic nephropathy by Yan Ren, Mengjie Yu, Danna Zheng, Wenfeng He, Juan Jin

    Published 2023-07-01
    “…Introduction Diabetic nephropathy (DN) is a leading cause of kidney failure. Lysozyme (LYZ) is an essential component of innate immunity and exhibits antibacterial properties. …”
    Get full text
    Article
  18. 1238

    Use of T1 mapping in cardiac MRI for the follow-up of Fabry disease in a pediatric population by Oscar Werner, Lydia Ichay, Nabila Djouadi, Fernando Vetromile, Marie Vincenti, Sophie Guillaumont, Dominique P. Germain, Marc Fila

    Published 2024-03-01
    “…Life threatening complications in adulthood include chronic kidney failure, strokes and the cardiac involvement which is the leading cause of mortality. …”
    Get full text
    Article
  19. 1239

    Trends in nephrology referral patterns for patients with chronic kidney disease: Retrospective cohort study. by Anukul Ghimire, Feng Ye, Brenda Hemmelgarn, Deenaz Zaidi, Kailash K Jindal, Marcello A Tonelli, Matthew Cooper, Matthew T James, Maryam Khan, Mohammed M Tinwala, Naima Sultana, Paul E Ronksley, Shezel Muneer, Scott Klarenbach, Ikechi G Okpechi, Aminu K Bello

    Published 2022-01-01
    “…The guideline concordant cohort were more likely to be on renin-angiotensin system blockers or beta blockers (hazard ratio 1.14, 95% confidence interval 1.12, 1.16), and had a higher risk of CKD progression (hazard ratio 1.09, 95% confidence interval 1.06, 1.13), kidney failure (hazard ratio 7.65, 95% confidence interval 6.83, 8.56), cardiovascular event (hazard ratio 1.40, 95% confidence interval 1.35,1.45) and mortality (hazard ratio 1.58, 95% confidence interval 1.52, 1.63).…”
    Get full text
    Article
  20. 1240

    Renal‐hepatic‐pancreatic dysplasia type 2: Perinatal lethal condition or a multisystemic disorder with variable expressivity by Kathryn Gunther, Essam M. Imseis, Joyce P. Samuel, Elizabeth A. Hillman, Tiina H. Ojala, Timo Jahnukainen, Paul R. Hillman

    Published 2023-04-01
    “…Of the four cases living past the first year of life, one case died at 5 years secondary to renal failure, the other at 30 months secondary to liver and kidney failure. Two are currently alive and well at one year and 13 years. …”
    Get full text
    Article